Bvf Inc Moon Lake Immunotherapeutics Transaction History
Bvf Inc
- $2.67 Billion
- Q4 2024
A detailed history of Bvf Inc transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Bvf Inc holds 19,751,284 shares of MLTX stock, worth $828 Million. This represents 39.28% of its overall portfolio holdings.
Number of Shares
19,751,284
Previous 21,751,284
9.19%
Holding current value
$828 Million
Previous $1.1 Billion
4.3%
% of portfolio
39.28%
Previous 34.86%
Shares
2 transactions
Others Institutions Holding MLTX
# of Institutions
136Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Cormorant Asset Management, LP Boston, MA8.49MShares$356 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$140 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$116 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$91.6 Million0.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY1.77MShares$74.3 Million3.59% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.55B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...